Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 820 citations · Full text

Medicine, Oncology, Pathology +17

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

Weiva Sieh, Martin Köbel, Teri A. Longacre et al. · The Lancet Oncology · 2013 · 432 citations · Full text

Medicine, Gynecology, Oncology +14

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum

David M. Gershenson, Diane C. Bodurka, Robert L. Coleman et al. · Journal of Clinical Oncology · 2017 · 272 citations · Full text

Medicine, Oncology, Surgery +17

The Dynamic Structure of the Estrogen Receptor

Raj Kumar, M. N. Zakharov, Shagufta H. Khan et al. · Journal of Amino Acids · 2011 · 246 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

Jacek Grabowski, Philipp Harter, Florian Heitz et al. · Gynecologic Oncology · 2016 · 230 citations

Medicine, Gynecology, Oncology +16